A

$ATRA

1 article found
0 positive
1 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Atara Biotherapeutics Hit With Class Action Over Misleading FDA Study Claims

Class action lawsuit filed against $ATARAWITH alleging executives made false statements about manufacturing issues and ALLELE study deficiencies that could block FDA approval of tabelecleucel.
ATRAsecurities fraudclass action lawsuit
$ATRA Stock News & Sentiment | MarketPulse